secwatch.observer — SEC 8-K summary
======================================

Issuer:     ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
CIK:        0001688757
Form:       8-K
Filed at:   2026-06-29T12:05:56+00:00
Accession:  0001628280-26-045885
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Establishment Labs appoints Taylor Harris to Board of Directors
---------------------------------------------------------------

- Taylor Harris appointed to Board effective June 24, 2026; will serve on Audit and Nominating & Governance Committees.
- 25+ years experience in healthcare, medtech, and life sciences; most recently CEO of Cutera and CFO of MyoKardia (acquired by BMS for $13.1B).
- New director receives initial equity grant of $170,000 under updated non-employee director compensation policy.
- Harris's appointment fills a board seat until the 2027 annual meeting; no arrangements or material interests with other parties.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1688757/000162828026045885/0001628280-26-045885-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1688757/000162828026045885/esta-20260629.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-045885

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer